One pill may be better than two for treating patients with high blood pressureMay 14, 2007Adults with high blood pressure and additional risk factors for heart disease may benefit more from taking one tablet rather than two, if their current treatment combines the lipid-lowering medication atorvastatin with the blood pressure-lowering medication amlodipine, researchers reported at the American Heart Association's 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke. In an analysis, researchers found that a single-tablet combination of the two medications is less costly than a two-tablet combination and is at least as effective, if not more so, in preventing cardiovascular events. Patients take the single-tablet medication or the two-tablet medication daily. "This is a novel research approach that examines the economic and clinical implications of high blood pressure and cholesterol in the real world," said Timothy W. Smith, lead author of the study and senior director of Informatics for ValueMedics Research (a unit of IMS Health Inc), a health outcomes research and consulting firm in Falls Church, Va. Researchers used a treatment approach and a population similar to the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid-Lowering Arm (ASCOT-LLA), which demonstrated the benefits of adding atorvastatin to high blood pressure treatment in adults with three or more risk factors for heart disease, including abnormal ratio of total-to-high density lipoprotein (HDL - the "good" cholesterol), previous stroke, male gender, 55 years or older and smoking.
In ASCOT-LLA, researchers examined 10,305 patients with high blood pressure and additional risk factors for heart disease with low-to-moderate cholesterol levels and found the addition of atorvastatin to high blood pressure treatment resulted in a significant reduction in unfavorable outcomes: fatal and non-fatal heart attack, stroke and chest pain. Nearly one in three U.S. adults has high blood pressure. About one-third of them do not know they have it. Uncontrolled high blood pressure can lead to stroke, heart attack, heart failure or kidney failure. High blood pressure is defined as systolic pressure of 140 mm Hg or higher or diastolic pressure of 90 mm Hg or higher. Systolic pressure is the force of blood in the arteries when the heart contracts to pump blood to the body. Diastolic pressure is the force in the arteries when the heart relaxes between beats. Normal blood pressure is less than 120 mm Hg systolic pressure and less than 80 mm Hg diastolic pressure. The results of the study showed that when hypothetical cohorts of 100,000 people fully adhered to the one-tablet and two-tablet regimens, each treatment group had 3,520 cardiovascular events over four years, such as fatal and non-fatal heart attack, chest pain and stroke. Medical costs over four years were $7,665 for the two-tablet regimen and $6,471 for the one-tablet regimen. A further analysis, examining the impact of lower compliance more typical in real-world populations, showed that four-year cardiovascular events increased for the two-tablet regimen to 6,990 versus 6,859 for the one-tablet regimen. Researchers concluded the one-tablet regimen was less costly and at least as effective as the two-tablet regimen. Sensitivity analyses confirmed these results when varying the effectiveness associated with partial adherence from 0 percent to 100 percent of the effectiveness of full adherence. Researchers in the ValueMedics study used U.S. databases to estimate direct medical costs and adverse treatment outcomes over four years among adults with similar characteristics to those examined in ASCOT-LLA. Amlodipine (brand name Norvasc) is in a class of medications called calcium channel blockers. It lowers blood pressure by relaxing the blood vessels so the heart does not have to pump as hard. Atorvastatin (brand name Lipitor) is in a class of medications known as statins or HMG-CoA reductase inhibitors. It lowers the level of cholesterol in the blood. A single tablet combination of amlodipine/atorvastatin is available as Caduet. American Heart Association | |||||||||||||||||||||
|
Related Blood Pressure Current Events and Blood Pressure News Articles Presence of gum disease may help dentists and physicians identify risk for cardiovascular disease Individuals reporting a history of periodontal disease were more likely to have increased levels of inflammation, a risk factor for heart disease, compared to those who reported no history of periodontal disease. Kidney function discovery sheds light on genetic complexity of disease To find a cure for cancer, haemophilia and other diseases, researchers need to be looking for complex, interacting genetic factors, according to the authors of a new study. Stanford/Packard study shows no benefit from drug widely used to prevent premature births When a pregnant woman goes into early labor, her obstetrician may give her drugs to quiet the woman's uterus and prevent premature birth. Potassium loss from blood pressure drugs may explain higher risk of adult diabetes Johns Hopkins researchers have discovered that a drop in blood potassium levels caused by diuretics commonly prescribed for high blood pressure could be the reason why people on those drugs are at risk for developing type 2 diabetes. Mechanisms of cardiovascular disease and cancer give clues to new therapies Cardiovascular conditions leading to heart attacks and strokes are treated quite separately from common cancers of the prostate, breast or lung, but now turn out to involve some of the same critical mechanisms at the molecular level. Heart patients are often not treated in accordance with guidelines Many patients with cardiovascular disease are not given adequate drug therapy. This is the result of an international study. In the current edition of Deutsches Ärzteblatt International, Uwe Zeimer et al. present the German results of this prospective, one-year survey. Study identifies causes of bone loss in breast cancer survivors Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss. Eye conditions linked with obstructive sleep apnea If a good night's sleep helps the brain and body perform better, it's a good guess that sleep problems can cause more than just fatigue. Numerous studies have shown a connection between sleep disorders and medical conditions such as cardiovascular disease, cerebrovascular disease, and metabolic disorders, including the risk of obesity and diabetes mellitus. In the November issue of Mayo Clinic Proceedings, Mayo Clinic researchers outline several interesting associations between sleep disorders and eye disease. New small-scale generator produces alternating current by stretching zinc oxide wires Researchers have developed a new type of small-scale electric power generator able to produce alternating current through the cyclical stretching and releasing of zinc oxide wires encapsulated in a flexible plastic substrate with two ends bonded. Sleep Apnea May Be Risk Factor for Sudden Cardiac Death, Mayo Clinic Research Concludes After studying the sleep characteristics of nearly 11,000 adults in an overnight sleep laboratory, Mayo Clinic researchers suggest that obstructive sleep apnea (OSA) - and, in particular, the low nighttime oxygen saturation of the blood it causes - may be a risk factor for sudden cardiac death (SCD). More Blood Pressure Current Events and Blood Pressure News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||